Condition: Alzheimer s Disease · Faecal Microbiota Transplantation (FMT) · Sponsor: University Hospital of North Norway
The goal of this study is to assess the feasibility and safety of faecal microbiota transplantation for Alzheimer's disease.
This description comes directly from the study's public registry record.
Mona Dixon Gundersen, MBChB, PhD · +47 77798916 · mona.dixon.gundersen@unn.no
Always discuss trial participation with your own doctor first.
| University Hospital of North Norway, Tromsø | Tromsø, Troms, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07332260